Skip to main content
Natera, Inc. logo

Natera, Inc. — Investor Relations & Filings

Ticker · NTRA ISIN · US6323071042 LEI · 529900CQ3OZ0A0VYVU59 US Human health and social work activities
Filings indexed 1,586 across all filing types
Latest filing 2017-02-09 Major Shareholding Noti…
Country US United States of America
Listing US NTRA

About Natera, Inc.

https://www.natera.com/

Natera, Inc. is a diagnostics company specializing in cell-free DNA (cfDNA) testing. The company develops and commercializes non-invasive tests focused on three primary areas: women's health, oncology, and organ health. In women's health, its products include the Panorama non-invasive prenatal test (NIPT) and the Horizon carrier screening test to assess genetic risks. The oncology portfolio features Signatera, a personalized molecular residual disease (MRD) test used to monitor cancer recurrence and treatment response. For organ health, its tests are designed to detect early signs of transplant rejection. Natera's technology aims to provide actionable information for personalized medical care, supported by extensive clinical validation through numerous peer-reviewed studies.

Recent filings

Filing Released Lang Actions
SC 13G/A Filing
Major Shareholding Notification
2017-02-09 English
4 Filing
Director's Dealing
2017-02-06 English
8-K Filing
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated January 31, 2017, reporting changes in the company's board of directors and senior management. It details the resignation of the CFO, appointment of a new CFO, increase in board size, and appointment of a new director. The content focuses on management changes and related compensatory arrangements. There are no financial statements or earnings data presented. The document fits the description of Board/Management Information filings, which announce changes in the company's board or senior management. Therefore, the appropriate classification is MANG (Board/Management Information). The document length (7164 characters) is sufficient to be the actual filing, not just an announcement. Confidence is high due to clear and explicit content about management changes.
2017-02-03 English
4 Filing
Director's Dealing
2017-01-06 English
4 Filing
Director's Dealing
2016-12-27 English
4 Filing
Director's Dealing
2016-12-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.